DASATINIB
NDC 59651-545, DASATINIB, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-545
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216547
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-545 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DASATINIB80 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-545-15 | 59651054515 | 1 BLISTER PACK in 1 CARTON (59651-545-15) / 15 TABLET in 1 BLISTER PACK |
| 59651-545-30 | 59651054530 | 30 TABLET in 1 BOTTLE (59651-545-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/58ce42c6-10bd-4bb4-bf89-eae8ed82c339
Use it
Look up 59651-545 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-545 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-545. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.